2026 NPPES data Urogynecology and Reconstructive Pelvic Surgery (Obstetrics & Gynecology) Physician NPI 1609842178 MD
Verify on CMS →

NINA DERESKA, MD

Urogynecology and Reconstructive Pelvic Surgery (Obstetrics & Gynecology) Physician in HOUSTON, Texas. CMS National Plan and Provider Enumeration System profile including specialty classification, practice address, and Medicare prescribing data when reported.

Federal data — no proprietary rating. PlainDoctor publishes the actual CMS NPPES and Medicare records — NPI registration, specialty, practice location, and prescribing data — without a composite score or editorial opinion on top. Every field traces to a federal source.
Prescribing volume
917
Medicare Part D claims · 262 beneficiaries · Urogynecology and Reconstructive Pelvic Surgery (Obstetrics & Gynecology) Physician avg: 611
Generic prescribing
75%
generic claims · 25% brand-name · higher generic rates reduce patient out-of-pocket costs
MIPS score
82.3883/100
▼ 1 pts below national avg 83.1 · [object Object]
Industry payments
$775.85
21 payments · CMS Open Payments (Sunshine Act)

What the federal data shows

NINA DERESKA, MD reported a CMS MIPS final score of 82.3883/100 — below the 83.1 national average — and filed 917 Medicare Part D claims in 2023.

82.3883/100
MIPS score · -1 vs avg
917
Part D claims, 2023
75%
generic prescribing
Likely
board-certified (heuristic)

Every figure on this page comes straight from federal CMS records (NPPES, Medicare Part D, MIPS, Open Payments) — no proprietary rating or editorial opinion is applied.

NINA DERESKA, MD's MIPS score vs every scored U.S. clinician

CMS Merit-based Incentive Payment System (MIPS) final score, 2023 — the federal quality measure

82 39th percentile higher than 39% of 477,587 scored providers

0–10: 8,684 scored providers (2%). Below this entry. 10–20: 3,008 scored providers (1%). Below this entry. 20–30: 3,069 scored providers (1%). Below this entry. 30–40: 2,746 scored providers (1%). Below this entry. 40–50: 2,928 scored providers (1%). Below this entry. 50–60: 5,882 scored providers (1%). Below this entry. 60–70: 13,906 scored providers (3%). Below this entry. 70–80: 118,074 scored providers (25%). Below this entry. 80–90: 129,887 scored providers (27%). This entry sits in this band. 90–100: 189,403 scored providers (40%). Above this entry. This provider 0 100 every MIPS-scored clinician, bucketed by value

Each bar is a band; taller bars hold more scored providers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source CMS Merit-based Incentive Payment System (MIPS) · 2023

Board certification likely (heuristic — not verified)

NINA DERESKA, MD practices in an ABMS-board-eligible specialty and shows active CMS Medicare participation + MIPS quality reporting + 2 hospital affiliations — signals consistent with board-certified status. For verified board certification, see CertificationMatters.org (the official ABMS public lookup).

What does the federal data show about NINA DERESKA, MD?

Near national average

NPI registry status

Active

Issued 02/24/2006

NPI 1609842178

Primary specialty

Urogynecology and Reconstructive Pelvic Surgery (Obstetrics & Gynecology) Physician

Niche

568 US NPIs in this specialty

Medicare Part D claims

917 50% vs specialty avg

2023 prescription claims

Specialty avg: 611

MIPS final score

82.3883/100 0.7116999999999933% pts

Above neutral band

vs 83.1 national avg

Specialty distribution in Texas

How Urogynecology and Reconstructive Pelvic Surgery (Obstetrics & Gynecology) Physician compares to other specialties among Texas providers

Texas providers

Urogynecology and Reconstructive Pelvic Surgery (Obstetrics & Gynecology) Physician share within Texas

1. Urogynecology and Reconstructive Pelvic Surgery (Obstetrics & Gynecology) Physician42%2. Internal medicine21%3. Family medicine17%4. Surgical12%5. Pediatric8%
Urogynecology and Reconstructive Pelvic Surgery (Obstetrics & Gynecology) Physician share within Texas

Medicare quality performance — MIPS

NINA DERESKA, MD's 2023 MIPS final score plotted against the Urogynecology and Reconstructive Pelvic Surgery (Obstetrics & Gynecology) Physician national average

Near national average
MIPS Final Score
82.3883/100
vs 83.1 national avg · 2023 performance year

MIPS final score (Urogynecology and Reconstructive Pelvic Surgery (Obstetrics & Gynecology) Physician) — 82.3883/100 vs national avg 83.1

0%100%National avg83%82.4%
MIPS final score (Urogynecology and Reconstructive Pelvic Surgery (Obstetrics & Gynecology) Physician) — 82.3883/100 vs national avg 83.1

The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.

Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).

NINA DERESKA, MD is a Urogynecology and Reconstructive Pelvic Surgery (Obstetrics & Gynecology) Physician provider practicing in HOUSTON, Texas, according to the CMS National Plan and Provider Enumeration System (NPPES). Credentials: MD. NPI: 1609842178. This profile includes practice location, specialty classification, and organizational affiliations from the CMS provider registry. Provider information is self-reported to CMS and updated monthly.

NINA DERESKA, MD appears in the CMS NPPES registry as a Urogynecology and Reconstructive Pelvic Surgery (Obstetrics & Gynecology) Physician provider holding MD credentials at 17510 W. GRAND PARKWAY S., HOUSTON, TX, 77479, with a listed phone of (713) 486-1530. NPI 1609842178 was issued on 02/24/2006. Because NPPES data is self-reported by the provider and refreshed monthly, the address, phone, and specialty reflect what DERESKA most recently submitted to CMS rather than a vetted directory listing, which is why patients should always confirm the practice is still at this location before scheduling.

Medicare Part D records for calendar year 2023 show 917 prescription claims written by this provider, covering 262 Medicare beneficiaries and totaling roughly $158K in drug spend, split 25% brand-name and 75% generic by claim count, with an opioid prescribing rate of 7.9%. These figures capture only Medicare Part D — commercial insurance, Medicaid, and cash-pay prescriptions are not included, and any drug-beneficiary cell under 11 is suppressed by CMS for patient privacy. On the CMS Merit-based Incentive Payment System, this provider earned a Final Score of 82.3883/100 for the 2023 performance year (Quality 79.2344, Cost 58.5062), compared with the national average of 83.1.

Urogynecology and Reconstructive Pelvic Surgery (Obstetrics & Gynecology) Physician is a narrow specialty nationwide, with 568 enrolled providers across 49 states and an average of 611 Part D claims per prescriber, so the context for interpreting these metrics differs meaningfully from a primary-care baseline. Important: PlainDoctor is a directory of publicly available government data, not medical advice, a malpractice database, or a quality rating. Inclusion here does not imply a recommendation, and absence of complaints or sanctions on this page does not mean none exist — always verify credentials through the NPPES NPI Registry, your state medical board, and the ABMS or AOA before making healthcare decisions.

Practice Address

17510 W. GRAND PARKWAY S.
HOUSTON, TX 77479

Provider Details

NPI 1609842178
Specialty Urogynecology and Reconstructive Pelvic Surgery (Obstetrics & Gynecology) Physician
Credentials MD
Gender Female
NPI Issued 02/24/2006

CMS Quality Score (MIPS)

Merit-based Incentive Payment System (MIPS) scores from CMS, 2023 performance year.

82.3883
Final Score
Avg: 83.1
79.2344
Quality
58.5062
Cost
100
Promoting Interoperability

Reporting: Group practice

Hospital and facility affiliations

Facilities where NINA DERESKA, MD bills Medicare from. Star ratings (1-5) are CMS Hospital Compare's "Hospital overall rating" — a composite of mortality, readmission, patient experience, safety, timely care, and efficient use of medical imaging measures. Source: CMS Care Compare.

HOUSTON FEMALE UROLOGY PA
HOUSTON, TX
UT PHYSICIANS
SUGAR LAND, TX

Affiliations sourced from CMS Doctors and Clinicians National Downloadable File; hospital ratings from CMS Hospital General Information dataset (cross-referenced by facility name + state).

Industry payments received (2024) — CMS Open Payments transparency data

The federal Physician Payments Sunshine Act (part of the Affordable Care Act) requires drug and medical-device manufacturers + group purchasing organizations to publicly report payments and other transfers of value to physicians and teaching hospitals. The data below covers 2024 for NINA DERESKA, MD. Source: openpaymentsdata.cms.gov.

Total received

$776

Largest payer

Boston Scientific Corporation

Most common payment type

Food and Beverage

Industry payments are not necessarily indicators of bias — they include research funding, consulting fees for evidence-based work, royalties for inventions, food at conferences, and similar items. The disclosure exists for transparency. Read our methodology for how we interpret this data.

License & disciplinary context — Texas TMB 2023 annual report

Aggregate state board data only — NOT a determination of any individual provider's status. The figures below describe statewide disciplinary activity across all ~77K Texas medical licensees in 2023 — they are NOT specific to NINA DERESKA, MD. To verify NINA DERESKA, MD's current license status, search the TMB public license lookup directly, or check the Federation of State Medical Boards (FSMB) verification service.

344
Total board actions, Texas 2023
Across 334 cases
4.47
Actions per 1,000 licensees
Texas statewide rate
probation
Most common action type
94 cases

TMB publishes annual disciplinary statistics as part of public-record reporting under each state's Administrative Procedure Act. See the full breakdown by action type and year on the Texas disciplinary trends page. Cross-checked against FSMB U.S. Medical Regulatory Trends.

Brand vs generic prescribing mix · Above average

NINA DERESKA, MD — brand share 25.0%
Specialty average (est.)

25% brand-name claims vs 75% generic, on 917 2023 Medicare Part D claims.

The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.

Medicare Part D Prescribing Data

CMS Medicare Part D prescriber-level data for calendar year 2023.

917
Total Claims
$158K
Total Drug Cost
262
Medicare Beneficiaries

Prescribing Breakdown

30-Day Fills
1,286
Total Day Supply
30,063
Brand vs Generic
25% brand / 75% generic
Brand Drug Cost
$124K
Generic Drug Cost
$33K
Opioid Claims
72 (7.9% rate)
Antibiotic Claims
134

Patient Demographics

Average Patient Age
73.6 years
Avg HCC Risk Score
0.99
Gender Split
100% female / 0% male
Age Distribution
<65: 14, 65-74: 138, 75-84: 90, 85+: 20

Top Prescribed Drugs (Medicare Part D)

Top drugs by claim count for calendar year 2023. Based on Medicare Part D data only.

Drug Claims
Solifenacin Succinate
121
Myrbetriq
Mirabegron
98
Ibuprofen
83
Methenamine Hippurate
69
Gemtesa
Vibegron
61
Promethazine Hcl
58
Tolterodine Tartrate Er
Tolterodine Tartrate
48
Nitrofurantoin Mono-Macro
Nitrofurantoin Monohyd/M-Cryst
45
Oxycodone-Acetaminophen
Oxycodone Hcl/Acetaminophen
39
Sulfamethoxazole-Trimethoprim
Sulfamethoxazole/Trimethoprim
39

* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.

Urogynecology and Reconstructive Pelvic Surgery (Obstetrics & Gynecology) Physician Overview

How NINA DERESKA, MD fits within the Urogynecology and Reconstructive Pelvic Surgery (Obstetrics & Gynecology) Physician landscape nationally.

568
Urogynecology and Reconstructive Pelvic Surgery (Obstetrics & Gynecology) Physician Providers in US
49
States with Urogynecology and Reconstructive Pelvic Surgery (Obstetrics & Gynecology) Physician
611
Avg Claims per Provider

NINA DERESKA, MD's 917 claims are above the specialty average of 611.

Nearby Urogynecology and Reconstructive Pelvic Surgery (Obstetrics & Gynecology) Physician Providers in Texas

Other clinicians with the same primary specialty enrolled in Texas, drawn from the same CMS NPPES roster as DERESKA.

Compare Urogynecology and Reconstructive Pelvic Surgery (Obstetrics & Gynecology) Physician nationally: see state-by-state distribution →

Frequently Asked Questions

What is NINA DERESKA, MD's specialty?
NINA DERESKA, MD specializes in Urogynecology and Reconstructive Pelvic Surgery (Obstetrics & Gynecology) Physician and practices in HOUSTON, Texas. Credentials: MD.
How much does NINA DERESKA, MD prescribe under Medicare Part D?
In 2023, NINA DERESKA, MD wrote 917 Medicare Part D claims totaling $158K in drug costs for 262 beneficiaries.
What is NINA DERESKA, MD's Medicare quality score?
NINA DERESKA, MD has a CMS MIPS Final Score of 82.3883/100 (Quality: 79.2344, Cost: 58.5062). The national average MIPS Final Score is 83.1. Source: CMS Merit-based Incentive Payment System (MIPS) 2023.
Where is NINA DERESKA, MD located?
NINA DERESKA, MD is located at 17510 W. GRAND PARKWAY S., HOUSTON, TX, 77479. Phone: (713) 486-1530.
What is NINA DERESKA, MD's NPI number?
NINA DERESKA, MD's National Provider Identifier (NPI) is 1609842178, issued on 02/24/2006.
Does NINA DERESKA, MD prescribe more brand-name or generic drugs?
NINA DERESKA, MD's prescribing is 25% brand-name and 75% generic drugs by claim count, with $124K in brand drug costs.
Does NINA DERESKA, MD prescribe opioids?
Yes, NINA DERESKA, MD had 72 opioid claims in 2023 with an opioid prescribing rate of 7.9%.
How many Urogynecology and Reconstructive Pelvic Surgery (Obstetrics & Gynecology) Physician providers are there in the US?
There are 568 Urogynecology and Reconstructive Pelvic Surgery (Obstetrics & Gynecology) Physician providers across 49 states in the US. The average Urogynecology and Reconstructive Pelvic Surgery (Obstetrics & Gynecology) Physician provider writes 611 Medicare Part D claims per year.
What drugs does NINA DERESKA, MD prescribe most often?
Based on 2023 Medicare Part D data, NINA DERESKA, MD's most frequently prescribed drugs include Solifenacin Succinate, Myrbetriq, Ibuprofen. This reflects Medicare Part D prescriptions only and does not include commercial insurance or other payer types.
Does NINA DERESKA, MD accept Medicare?
NINA DERESKA, MD appears in CMS Medicare data with 917 Part D claims and 262 Medicare beneficiaries in 2023. Contact the provider's office directly to confirm current Medicare enrollment and accepted plans.
How can I verify NINA DERESKA, MD's credentials?
NINA DERESKA, MD's NPI is 1609842178 with credentials MD. You can verify this through the NPPES NPI Registry, check state medical board records, and confirm board certification through the ABMS or AOA.

Data Sources

Provider Directory
CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
Specialty Classification
NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
Prescribing Data
CMS Medicare Part D Prescriber Public Use File (2023). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
Quality Performance
CMS Merit-based Incentive Payment System (MIPS) — 2023 performance year.
Limitations
Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.

See our complete data methodology for details on how we collect and process government data.

Data as of April 2026 (NPPES) / 2023 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).

Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology